Cleared Traditional

K050778 - TELEREHAD 2004

K050778 is an FDA 510(k) clearance for TELEREHAD 2004, manufactured by Scottcare. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Traditional 510(k) pathway after a 16-day FDA review.

K050778 · Scottcare · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Apr 2005
Decision
16d
Days
Class 2
Risk

K050778 is an FDA 510(k) clearance for the TELEREHAD 2004. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Scottcare (Cleveland, US). The FDA issued a Cleared decision on April 13, 2005 after a review of 16 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K050778

510(k) Number K050778 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 28, 2005
Decision Date April 13, 2005
Days to Decision 16 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
109d faster than avg
Panel avg: 125d · This submission: 16d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Entela, Inc.
NED DEVINE

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 188
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K050778.
REMOTE CARE MANAGEMENT SYSTEMS (RCMS)
K051470 · Bl Healthcare, Inc. · Jun 2005
THE HERMES SYSTEM
K050929 · Palaistra Systems, Inc. · May 2005
VITALWARE VMS
K050128 · Televital, Inc. · May 2005
HEALTH BUDDY APPLIANCE
K050567 · Health Hero Network, Inc. · Apr 2005
RTX3320PSTN WIRELESS TELEHEALTH GATEWAY
K041816 · Rtx Healthcare A/S · Jul 2004
TELENABLE EMS SYSTEM
K040663 · Molex, Inc. · Jun 2004
K050778 · TELEREHAD 2004
Download PDF FDA Summary Scottcare